Comprehensive molecular profiling of FH-deficient renal cell carcinoma identifies molecular subtypes and potential therapeutic targets.
Zhang X, Zhao J, Yin X, Liang J, Wang Y, Zheng L, Tan P, Lin Y, Xu N, Zhu S, Chen J, Zhao J, Hu X, Pan X, Nie L, Zhang M, Chen Y, Zhang Y, Liu H, Dai J, Wang Z, Liu H, Ni Y, Rupp NJ, Moch H, Sheng X, Gong K, Liu X, Chen Z, He Z, Wang Y, Xu L, Liu M, Zhou H, Tang B, Huang R, Wei Q, Li X, Liu J, Yao J, Liao B, Liu Z, Shen P, Chen N, Zeng H, Sun G.
Zhang X, et al. Among authors: rupp nj.
Nat Commun. 2025 May 12;16(1):4398. doi: 10.1038/s41467-025-59513-8.
Nat Commun. 2025.
PMID: 40355427
Free PMC article.